Related Experiment Video
Updated: Jan 9, 2026

Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
Creutzfeldt-Jakob Disease: Insights from a Case Report and Diagnostic Challenges
Harikrishna Choudary Ponnam1, Kunal Sonavane2, Pallavi Shirsat3
1Internal Medicine, Summa Health, Akron, USA.
Abstract:
Creutzfeldt-Jakob disease (CJD) is a rare, rapidly progressive, and fatal neurodegenerative disorder caused by abnormal prion proteins. Due to its often nonspecific and variable early symptoms, CJD is frequently misdiagnosed as a psychiatric or other neurodegenerative condition, creating significant diagnostic challenges. Timely recognition is crucial but remains difficult due to its rarity and overlap with more common disorders. We describe a 66-year-old male patient who was initially admitted to a psychiatric unit with prominent behavioral disturbances and mood changes. The clinical presentation was initially attributed to a primary psychiatric illness, particularly bipolar disorder. Brain imaging and electroencephalogram (EEG) were inconclusive. However, cerebrospinal fluid (CSF) analysis revealed findings consistent with prion disease, confirming the diagnosis of CJD. The patient's neurological function deteriorated rapidly, and he died within two months of diagnosis. This case highlights the diagnostic complexity of CJD, especially in its early stages when psychiatric symptoms may predominate. A high index of suspicion and early use of CSF biomarkers are essential for timely diagnosis. Clinicians should consider CJD in the differential diagnosis of rapidly progressive neuropsychiatric syndromes, as early recognition, although not curative, can guide appropriate care and family counseling.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Acute Pyelonephritis II: Diagnostic Studies and Management

